1. What is the Orange Healthcare CD2 (Pan T Cell Marker) Test?
It is a specialised laboratory test used to detect CD2 protein expression on immune cells, particularly T lymphocytes and natural killer cells, to help identify and characterise these cell populations.
2. Why is the CD2 (Pan T Cell Marker) Test performed?
The test is performed to support the diagnosis and classification of T-cell lymphomas, leukaemias, and other lymphoproliferative disorders. It is commonly used as part of a broader immunophenotyping panel.
3. What does a positive CD2 result indicate?
A positive result indicates CD2 expression in the examined cells. This may support T-cell or natural killer cell lineage, depending on other markers. CD2 positivity alone does not indicate cancer or confirm a specific diagnosis.
4. What does a negative CD2 result indicate?
A negative result indicates that CD2 expression was not detected in the examined cell population. Loss of CD2 expression may occur in certain abnormal T-cell populations, but the finding must be interpreted alongside other immunophenotypic markers.
5. Is fasting required for the Orange Healthcare CD2 (Pan T Cell Marker) Test?
Fasting is generally not required. However, if tissue collection, bone marrow aspiration, or another procedure is planned, patients should follow the preparation instructions provided by their healthcare team.
6. What sample is required for the CD2 (Pan T Cell Marker) Test?
The required specimen depends on the testing method and clinical indication. Tissue biopsy samples are commonly used for immunohistochemistry, while peripheral blood, bone marrow, or fresh tissue samples may be analysed using flow cytometry. The laboratory determines the appropriate specimen and testing method.